Someit Sidhu, JATT Acquisition CEO
After raising $140M, SPAC will take biotech public with a fraction of planned funds
A SPAC closed its merger with its private biotech partner Tuesday morning, sending the company to Nasdaq with extra cash in its coffers. But the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
